CADL
Candel Therapeutics Inc.
$5.31
+$0.08(+1.53%)
54
Overall
--
Value
54
Tech
--
Quality
Market Cap
$266.24M
Volume
790.09K
52W Range
$3.79 - $14.60
Target Price
$21.00
EPS Estimates Overview
| Current Quarter | $-0.18 | Next Quarter | $-0.23 |
| Current Year | $-0.4 | Next Year | $-0.48 |
| QoQ Growth | -27.8% | YoY Growth | -20.0% |
| 3Y EPS CAGR | +3.1% | Target Price | $21.00 |
| Consensus | Buy | Upside | +295.5% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CADL | $5.31 | +1.5% | 790.09K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Candel Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW